AI Insight
Researchers discovered that Pseudomonas aeruginosa biofilms use a filamentous bacteriophage called Pf4 to form liquid crystalline droplets that protect bacteria from antibiotics. They developed nanobodies that bind to the phage surface and disrupt these protective structures, successfully restoring antibiotic susceptibility in biofilms. The study demonstrates that targeting the biophysical properties of biofilm components, rather than specific biochemical pathways, can overcome antibiotic resistance.
Why it matters
This approach offers a potential new strategy to combat antibiotic-resistant P. aeruginosa infections, which are a major clinical problem in hospitals and in patients with cystic fibrosis. The principle of disrupting protective liquid crystalline structures could be applied to biofilms formed by other pathogenic bacteria, providing a broader framework for treating difficult-to-eradicate bacterial infections.
by Abul K. Tarafder, Miles Graham, Luke K. Davis, Shawna Pratt, Jan Böhning, Pavithra Manivannan, Zhexin Wang, Camila M. Clemente, Aaron Weimann, R. Andres Floto, Raymond J. Owens, George A. O’Toole, Philip Pearce, Tanmay A. M. Bharat
All bacterial biofilms contain an extracellular matrix rich in filamentous molecules that self-associate, conferring emergent properties to bacteria, including antibiotic tolerance. Pseudomonas aeruginosa is a human pathogen that forms biofilms in diverse infectious settings, where the upregulation of a filamentous bacteriophage Pf4, has been shown to be a key virulence factor that protects bacteria from antibiotics. Here, we modeled biophysical characteristics of biofilm-linked liquid crystalline droplets formed by Pf4, which predicted that sub-stoichiometric phage binders had the ability to disrupt liquid crystals by changing the surface properties of the phage. We tested this prediction by developing nanobodies targeting the outer surface of the Pf4 phage, which disrupted in vitro reconstituted droplets, promoted antibiotic diffusion into bacteria, disrupted P. aeruginosa biofilm formation under a variety of conditions, and abolished antibiotic tolerance of biofilms. The inhibition strategy illustrated in this study could be extended to biofilms of other pathogenic bacteria, where filamentous molecules are pervasive in the extracellular matrix. Furthermore, our findings exemplify how targeting a biophysical mechanism, rather than a defined biochemical target, is a promising avenue for intervention, with the potential of applying this concept to other disease-related contexts.